Gene Editing Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Others), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
The global Gene Editing market size is poised to register 16.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gene Editing market across By Products and Services (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Others), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others)
The gene editing market is driven by the increasing demand for genome engineering tools and gene therapy applications, advancements in gene editing technologies and delivery systems, and the growing interest in precision medicine and genetic disease treatment. By 2030, the market is anticipated to witness significant growth, fueled by innovations in CRISPR-Cas9, TALENs, and zinc finger nucleases. Further, expanding applications in gene knockout, gene knock-in, and gene correction are expected to drive market expansion, enabling researchers, biotech companies, and healthcare providers to edit the genome, modulate gene expression, and develop novel therapies through gene editing solutions that offer specificity, efficiency, and safety for targeted genome modification and therapeutic gene delivery in preclinical and clinical settings.
Gene Editing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gene Editing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gene Editing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gene Editing industry.
Key market trends defining the global Gene Editing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gene Editing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gene Editing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gene Editing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gene Editing industry
Leading Gene Editing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gene Editing companies.
Gene Editing Market Study- Strategic Analysis Review
The Gene Editing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Gene Editing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gene Editing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gene Editing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gene Editing market segments. Similarly, Strong market demand is encouraging Canadian Gene Editing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gene Editing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gene Editing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gene Editing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gene Editing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gene Editing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gene Editing in Asia Pacific. In particular, China, India, and South East Asian Gene Editing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gene Editing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gene Editing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gene Editing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gene Editing.
Gene Editing Market Company Profiles
The global Gene Editing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, AMS Biotechnology Ltd, Beam Therapeutics Inc, Bluebird Bio Inc, Caribou Biosciences Inc, Cellectis S.A., Creative Biogene, CRISPR Therapeutics AG, Editas Medicine Inc, GenScript Biotech Corp, Inscripta Inc, Intellia Therapeutics Inc, Lonza Group Ltd, Mammoth Biosciences Inc, Merck KGaA, New England Biolabs Inc, OriGene Technologies Inc, PerkinElmer Inc, Precision Biosciences Inc, Regeneron Pharmaceuticals Inc, Sangamo Therapeutics Inc, Synthego Corp, Tecan Group Ltd, Thermo Fisher Scientific Inc.
Recent Gene Editing Market Developments
The global Gene Editing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gene Editing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Geographical Segmentation:
Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The gene editing market is driven by the increasing demand for genome engineering tools and gene therapy applications, advancements in gene editing technologies and delivery systems, and the growing interest in precision medicine and genetic disease treatment. By 2030, the market is anticipated to witness significant growth, fueled by innovations in CRISPR-Cas9, TALENs, and zinc finger nucleases. Further, expanding applications in gene knockout, gene knock-in, and gene correction are expected to drive market expansion, enabling researchers, biotech companies, and healthcare providers to edit the genome, modulate gene expression, and develop novel therapies through gene editing solutions that offer specificity, efficiency, and safety for targeted genome modification and therapeutic gene delivery in preclinical and clinical settings.
Gene Editing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gene Editing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gene Editing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gene Editing industry.
Key market trends defining the global Gene Editing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gene Editing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gene Editing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gene Editing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gene Editing industry
Leading Gene Editing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gene Editing companies.
Gene Editing Market Study- Strategic Analysis Review
The Gene Editing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Gene Editing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gene Editing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gene Editing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gene Editing market segments. Similarly, Strong market demand is encouraging Canadian Gene Editing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gene Editing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gene Editing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gene Editing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gene Editing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gene Editing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gene Editing in Asia Pacific. In particular, China, India, and South East Asian Gene Editing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gene Editing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gene Editing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gene Editing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gene Editing.
Gene Editing Market Company Profiles
The global Gene Editing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, AMS Biotechnology Ltd, Beam Therapeutics Inc, Bluebird Bio Inc, Caribou Biosciences Inc, Cellectis S.A., Creative Biogene, CRISPR Therapeutics AG, Editas Medicine Inc, GenScript Biotech Corp, Inscripta Inc, Intellia Therapeutics Inc, Lonza Group Ltd, Mammoth Biosciences Inc, Merck KGaA, New England Biolabs Inc, OriGene Technologies Inc, PerkinElmer Inc, Precision Biosciences Inc, Regeneron Pharmaceuticals Inc, Sangamo Therapeutics Inc, Synthego Corp, Tecan Group Ltd, Thermo Fisher Scientific Inc.
Recent Gene Editing Market Developments
The global Gene Editing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gene Editing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Gene Editing Market Overview and Key Findings, 2024
1.2 Gene Editing Market Size and Growth Outlook, 2021- 2030
1.3 Gene Editing Market Growth Opportunities to 2030
1.4 Key Gene Editing Market Trends and Challenges
1.4.1 Gene Editing Market Drivers and Trends
1.4.2 Gene Editing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gene Editing Companies
2. GENE EDITING MARKET SIZE OUTLOOK TO 2030
2.1 Gene Editing Market Size Outlook, USD Million, 2021- 2030
2.2 Gene Editing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENE EDITING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENE EDITING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gene Editing Market, 2025
5.2 Asia Pacific Gene Editing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gene Editing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gene Editing Market, 2025
5.5 Europe Gene Editing Market Size Outlook by Type, 2021- 2030
5.6 Europe Gene Editing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gene Editing Market, 2025
5.8 North America Gene Editing Market Size Outlook by Type, 2021- 2030
5.9 North America Gene Editing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gene Editing Market, 2025
5.11 South America Pacific Gene Editing Market Size Outlook by Type, 2021- 2030
5.12 South America Gene Editing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gene Editing Market, 2025
5.14 Middle East Africa Gene Editing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gene Editing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gene Editing Market Size Outlook and Revenue Growth Forecasts
6.2 US Gene Editing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gene Editing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gene Editing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gene Editing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gene Editing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gene Editing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gene Editing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gene Editing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gene Editing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gene Editing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gene Editing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gene Editing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gene Editing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gene Editing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gene Editing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gene Editing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gene Editing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gene Editing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gene Editing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gene Editing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gene Editing Industry Drivers and Opportunities
7. GENE EDITING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENE EDITING COMPANY PROFILES
8.1 Profiles of Leading Gene Editing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Gene Editing Market Overview and Key Findings, 2024
1.2 Gene Editing Market Size and Growth Outlook, 2021- 2030
1.3 Gene Editing Market Growth Opportunities to 2030
1.4 Key Gene Editing Market Trends and Challenges
1.4.1 Gene Editing Market Drivers and Trends
1.4.2 Gene Editing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gene Editing Companies
2. GENE EDITING MARKET SIZE OUTLOOK TO 2030
2.1 Gene Editing Market Size Outlook, USD Million, 2021- 2030
2.2 Gene Editing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENE EDITING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENE EDITING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gene Editing Market, 2025
5.2 Asia Pacific Gene Editing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gene Editing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gene Editing Market, 2025
5.5 Europe Gene Editing Market Size Outlook by Type, 2021- 2030
5.6 Europe Gene Editing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gene Editing Market, 2025
5.8 North America Gene Editing Market Size Outlook by Type, 2021- 2030
5.9 North America Gene Editing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gene Editing Market, 2025
5.11 South America Pacific Gene Editing Market Size Outlook by Type, 2021- 2030
5.12 South America Gene Editing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gene Editing Market, 2025
5.14 Middle East Africa Gene Editing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gene Editing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gene Editing Market Size Outlook and Revenue Growth Forecasts
6.2 US Gene Editing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gene Editing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gene Editing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gene Editing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gene Editing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gene Editing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gene Editing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gene Editing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gene Editing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gene Editing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gene Editing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gene Editing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gene Editing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gene Editing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gene Editing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gene Editing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gene Editing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gene Editing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gene Editing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gene Editing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gene Editing Industry Drivers and Opportunities
7. GENE EDITING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENE EDITING COMPANY PROFILES
8.1 Profiles of Leading Gene Editing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
